ONCOR, INC. EMPLOYMENT AND MANAGEMENT CONTINUITY AGREEMENTEmployment Agreement • May 22nd, 1998 • Oncor Inc • In vitro & in vivo diagnostic substances • Maryland
3 4 rata portion (based on the number of Initial Preferred Shares each Buyer purchased in relation to the total number of Initial Preferred Shares purchased by the Buyers) of the aggregate number of Put Preferred Shares, along with the related...Securities Purchase Agreement • February 25th, 1998 • Oncor Inc • In vitro & in vivo diagnostic substances • New York
b) the term "Warrant Holder" shall mean the Purchaser or any assignee of all or any portion of this Warrant at any given time who, at the time of assignment, acquired the right to purchase at least 1000 Warrant Shares (such number being subject to...Common Stock Purchase Warrant • February 28th, 1997 • Oncor Inc • In vitro & in vivo diagnostic substances
1 EXHIBIT 10.2 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "AGREEMENT"), dated as of January 8, 1998, by and among Oncor, Inc., a Maryland corporation, with headquarters located at 209 Perry Parkway, Gaithersburg, Maryland 20872...Registration Rights Agreement • February 25th, 1998 • Oncor Inc • In vitro & in vivo diagnostic substances • New York
AND ONCOR, INC. 200 PERRY PARKWAYLease Agreement • May 15th, 1997 • Oncor Inc • In vitro & in vivo diagnostic substances
EXHIBIT A --------- ONCOR, INC. ----------- STOCK OPTION AGREEMENT ---------------------- WITNESSETH: -----------Stock Option Agreement • January 29th, 1996 • Oncor Inc • In vitro & in vivo diagnostic substances • Maryland
c) Performance by the Subscriber. The Subscriber shall have performed, satisfied and complied in all respects with all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Subscriber at or...Subscription Agreement • February 28th, 1997 • Oncor Inc • In vitro & in vivo diagnostic substances • New York
1 EXHIBIT 10.1 STOCK EXCHANGE AGREEMENT THIS STOCK EXCHANGE AGREEMENT (the "Agreement") is made as of the 24th day of February, 1998, by and among Oncor, Inc., a Maryland corporation ("Oncor"), and the persons listed on Schedule A hereto...Stock Exchange Agreement • September 2nd, 1998 • Oncor Inc • In vitro & in vivo diagnostic substances • Maryland
b) Accuracy of the Subscriber's Representation and Warranties. The representations and warranties of the Subscriber shall 3 - 3 -Subscription Agreement • January 24th, 1997 • Oncor Inc • In vitro & in vivo diagnostic substances • New York
WITNESSETH: ----------Non-Statutory Stock Option Agreement • January 29th, 1996 • Oncor Inc • In vitro & in vivo diagnostic substances • Maryland
FOR VALUE RECEIVED, the Company promises to pay to ______________________, having an address at ______________________, the holder hereof, or its order (the "Holder"), the principal sum of ______________________ United States Dollars (U.S. $_______)...Convertible Debenture Agreement • February 28th, 1997 • Oncor Inc • In vitro & in vivo diagnostic substances
ONCOR, INC. -----------Non-Employee Director Automatic Stock Option Agreement • January 29th, 1996 • Oncor Inc • In vitro & in vivo diagnostic substances • Maryland
ONCOR, INC. MANAGEMENT CONTINUITY AGREEMENTManagement Continuity Agreement • May 22nd, 1998 • Oncor Inc • In vitro & in vivo diagnostic substances • Maryland
